Kukje Pharma Co (XKRX:002720) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XKRX:002720 Kukje Pharma Co Ltd XKRX:002720
65 GF Score
Price ₩3,325.00
GF Value ₩5,934.79
Valuation Possible Value Trap
! 1 Warning Sign
View Full Analysis

What is Kukje Pharma Co Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

XKRX:002720 vs ZTS: Short Interest Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Kukje Pharma Co's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kukje Pharma Co Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kukje Pharma Co's Short Interest distribution charts can be found below:

* The bar in red indicates where Kukje Pharma Co's Short Interest falls into.


XKRX:002720
65GF Score
Kukje Pharma Co Ltd XKRX:002720
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Kukje Pharma Co (XKRX:002720) Overvalued in 2026?

Based on GuruFocus' analysis, Kukje Pharma Co stock appears to be undervalued. The current stock price of ₩3,325.00 is trading 44% below its estimated GF Value™ of ₩5,934.79. GuruFocus considers Kukje Pharma Co to be Possible Value Trap.

Key valuation signals for XKRX:002720:

  • Short Interest:
  • GF Value™: ₩5,934.79 vs. price of ₩3,325.00 (44% below fair value)
  • GF Score™: 65/100 with 1 warning sign

No single metric tells the full story. See the XKRX:002720 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Kukje Pharma Co Business Description

Address 96-8 Yatap-ro, Bundang-Gu, Gyeonggi-do, Seongnam-si, KOR, 463-839
Kukje Pharma Co Ltd is engaged in the manufacturing and sales of pharmaceutical products, and it handles over-the-counter and prescription drugs such as Q-Allon eye drops, Letium tablets, Ezerova tablets, Colencia soft capsules, and International Cephazedon injection.
65GF Score

Get the complete analysis for XKRX:002720

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₩3,325.00
Price
₩5,934.79
GF Value